Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ENCEFA Logo
ENCEFA Growth Score
39
CB Rank
146078
Heat Score
65
ENCEFA is a biotech company that develops modulate CD38 drugs for age-related diseases.
Founded
obfuscation
PrivateSeed La Maison, Bourgogne, France1-10 www.encefa.com
Biotechnology
Life Science
Pharmaceutical
Wellness
Overview

ENCEFA
Total Funding
obfuscation
Growth Score
39
Heat Score
65

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score39
1 pts
in past quarter
Heat Score 65
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ENCEFA

CB Rank
146078
ENCEFA is a biotech company that develops modulate CD38 drugs for age-related diseases.
Founded
obfuscation
PrivateSeed La Maison, Bourgogne, France1-10 www.encefa.com
Biotechnology
Life Science
Pharmaceutical
Wellness

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name ENCEFA - ENVA
Operating Status Active
Company Type For Profit
Founders  Damien Toulorge, Laurence Bressac, Serge Guerreiro
About the Company

ENCEFA is a biopharmaceutical enterprise that creates medications that precisely control CD38, a target associated with aging, to save vital organs like the brain, heart, and kidney in the context of neurodegenerative, metabolic, inflammatory, and age-related disorders. To repair inflammation and protect tissues, their products activate

intracellular clearance and energy metabolism in CD38+ cells.

Phone Number +33 15 72 74 000
Contact Email contact@encefa.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

NC-B8 Antibody
A drug candidate that modulates CD38 to activate autophagy-lysosomal flux and energy metabolism in neurons, aimed at neuroprotection in neurodegenerative diseases such as ALS.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
1
obfuscation
— Seed
obfuscation
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
1
obfuscation
— Seed
obfuscation
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
1
obfuscation
— Seed
obfuscation
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
1
obfuscation
— Seed
obfuscation
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
1
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
1
obfuscation
— Seed
obfuscation
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
1
obfuscation
— Seed
obfuscation
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
1
obfuscation
— Seed
obfuscation
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
1
obfuscation
— Seed
obfuscation
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
1
obfuscation
— Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Newchip Accelerator Logo
Newchip Accelerator
—
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
—
Newchip Accelerator Logo
Newchip Accelerator
—
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
—
Newchip Accelerator Logo
Newchip Accelerator
—
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
—
Newchip Accelerator Logo
Newchip Accelerator
—
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
—
Newchip Accelerator Logo
Newchip Accelerator
—
Seed Round - ENCEFA Logo
Seed Round - ENCEFA
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 1

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

30

Active Website Tech Count

16ENCEFA is actively using 16 technologies for its website, according to BuiltWith. These include WordPress, Cloudflare, and  Cloudflare CDN.

Total IP

3The intellectual property of ENCEFA includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is ENCEFA's headquarters? ENCEFA is located in La Maison, Bourgogne, France.Who invested in ENCEFA? ENCEFA is funded by Newchip Accelerator.When was the last funding round for ENCEFA? ENCEFA closed its last funding round on
obfuscation
from a Seed round.Who are ENCEFA's competitors? Alternatives and possible competitors to ENCEFA may include Amylyx Pharmaceuticals, Life Biosciences, and  Coya Therapeutics.How much funding has ENCEFA raised to date? ENCEFA has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(69c1996 1)
|